This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

PharmaSOL Delivers Oracle Accelerate RapidLIVE Solution For Life Sciences In The United States

KAISERSLAUTERN, Germany, March 20, 2013 /PRNewswire/ --  pharmaSOL, a Gold member of the Oracle PartnerNetwork, today announced that rapidLIVE, an Oracle Accelerate solution for the Life Sciences industry, is now available in the United States. The Oracle Accelerate rapidLIVE solution is designed with the required components to go-live with a new system in a short timeframe, whilst adhering to the highest industry standards relating to system validation and documentation.  The Oracle Accelerate rapidLIVE solution is available for Oracle Clinical, Oracle Remote Data Capture (RDC), Oracle Thesaurus Management System (TMS), Oracle Adverse Event Reporting System (AERS) and Oracle Argus Safety.  pharmaSOL is an Oracle Accelerate solution provider for Oracle Health Sciences and a Gold level member in Oracle PartnerNetwork (OPN).

The Oracle Accelerate rapidLIVE solution delivered by pharmaSOL allows clients to cost-effectively implement leading commercial life science systems, including Oracle's Health Sciences technology, enabling them to be in production in just a few weeks. This Oracle Accelerate solution is already available in several countries in Europe. 

rapidLIVE provides an accelerated deployment package, with industry best practice configurations, a streamlined validation test package and in-depth instructor-led modular training. Offered as an affordable fixed-cost solution with flexible licensing, rapidLIVE can be implemented on-premise at the client's site or via the cloud in conjunction with pharmaSOL's hosting/SaaS offering.

"We are excited to be able to further our presence in North America. Our innovative technology solutions, such as Oracle Accelerate rapidLIVE, coupled with our team of industry-leading experts, will now provide North American clients the differentiating advantages across Oracle's broad Health Sciences' suite that our European clientele have become accustomed to experiencing over the past 12 years," said Sheldon Wong, pharmaSOL's US-based chief operating officer.

"Used by midsize companies around the world, Oracle Accelerate solutions combine Oracle's best-in-class software with our knowledgeable partners to help life science organizations achieve needed industry specific functionality and a quick return on investment,"  said Steve Cox, vice president, Oracle Accelerate for Midsize Companies."

About Oracle Accelerate

Oracle Accelerate provides simple to deploy, packaged, enterprise-class software solutions to growing midsize organizations through Oracle's network of expert partners. Created by Oracle's expert partners, Oracle Accelerate solutions are simple to deploy, industry-specific packaged solutions, designed for fast time to benefit, which means getting the right solution in place quickly, inexpensively and with a controlled scope and predictable returns. The best Oracle Accelerate Solutions are based on Oracle Business Accelerators, which are powerful, cloud-based rapid implementation tools developed and maintained by Oracle to get you up and running on a wide range of Oracle Applications, both quickly and reliably. Oracle has more than 290,000 midsize customers who buy Oracle to grow. To find out more, visit

About Oracle PartnerNetwork

Oracle PartnerNetwork (OPN) Specialized is the latest version of Oracle's partner program that provides partners with tools to better develop, sell and implement Oracle solutions. OPN Specialized offers resources to train and support specialized knowledge of Oracle products and solutions and has evolved to recognize Oracle's growing product portfolio, partner base and business opportunity. Key to the latest enhancements to OPN is the ability for partners to differentiate through Specializations. Specializations are achieved through competency development, business results, expertise and proven success. To find out more visit

About pharmaSOL

pharmaSOL is a leading provider of innovative technology solutions and expert consulting services for the life sciences industry. Providing high quality capabilities to our pharmaceutical, biotechnology, CROs and regulatory partners for over 12 years, we are committed to delivering efficient and practical end-to-end solutions that allow our clients to focus more successfully on their core business needs.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.74 -1.15%
FB $117.58 0.73%
GOOG $693.01 0.29%
TSLA $240.76 -2.81%
YHOO $36.60 0.03%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs